TORONTO (AP) — TORONTO (AP) — Intellipharmaceutics International Inc. (IPCIF) on Tuesday reported a loss of $875,000 in its fiscal fourth quarter.
The Toronto-based company said it had a loss of 9 cents per share.
The extended-release drug developer posted revenue of $46,700 in the period. Its adjusted revenue was $47,000.
For the year, the company reported a loss of $2.9 million, or 9 cents per share. Revenue was reported as $657,000.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a IPCIF">Zacks stock report on IPCIF at https://www.zacks.com/ap/IPCIF